First Data for ImmunityBio’s Memory Cytokine-Enriched NK Cells in Small Cell Lung Cancer at SITC Meeting Show Promising Anti-tumor Activity
Small cell lung cancer (SCLC) is an aggressive neuroendocrine (NE) carcinoma and has few treatment options.
- Small cell lung cancer (SCLC) is an aggressive neuroendocrine (NE) carcinoma and has few treatment options.
- In the new study, the killing capacity of M-ceNK cells was assessed in four SCLC cell lines representing the major molecular subtypes.
- The M-ceNK cells were highly cytotoxic against all types of SCLC models, as well as against prostate neuroendocrine cancer.
- “We are encouraged by the data coming out of this study and we look forward to assessing the potential for M-ceNK therapy in other tumor types.”